News

business partnership handshake merger acquisition M&A

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

Thumbnail

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care. 

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.

Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.

Caon Medical USA ultrasound director Dan Skyba explains advances in ultrasound processing algorithms at RSNA 2025.

The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.

Financial data showing growing revenue

The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward. 

small hospital

One of the AI haves feels the pain of the AI have-nots. His discomfort is especially pronounced when he thinks about how hard it must be for financial strugglers to keep up with regulations and rumors of regulations to come.

Thumbnail

It's slated to become the 31st state to finalize legislation eliminating out-of-pocket costs for follow-up exams after an abnormal screening mammogram. 

the words "FDA recall" on a board

Rechargeable batteries used on CADD-Solis Li-ion infusion systems may short out if damaged, possibly causing the case to melt. No injuries have been reported.

artificial intelligence robot evaluates healthcare data

“When we rely too much on whatever the computer tells us, that’s a problem."

Abbott FreeStyle Libre 3 CGM

Abbott expects the new facility to produce more FreeStyle Libre 3 sensors than anywhere else in the world.

Thumbnail

By expediting communication between radiologists and referring providers when suspicious findings are identified, the system has great potential to improve clinical outcomes in real-world scenarios, authors of a new study in JACR suggest.

Around the web

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care. 

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.